Influence of Levocarnitin Treatment during a Stable Ischemic Heart Disease in Patients with Non-Alcoholic Fatty Liver Disease and Obesity
Shevchenko T. I., Sorokina S. I., Kudrya I. P., Shaposhnyk O. A.
JMBS 2017, 2(4): 121–126 https://doi.org/10.26693/jmbs02.04.121